David Reissner, Partner
David is an expert in pharmacy law, administrative and public law (including Judicial Review) and healthcare law.
SummaryDavid is an expert in pharmacy law, administrative and public law (including Judicial Review) and healthcare law. He advises on a range of NHS and other legal and ethical issues. His clients include representative bodies, pharmacy owners, individual pharmacists, dentists, GPs and other healthcare professionals.
David appears regularly as a solicitor advocate at NHS hearings and in fitness to practise proceedings at the General Pharmaceutical Council. He received a lifetime achievement award in 2013 from the Propharm Pharmacy Group for services to the pharmacy profession and in 2015 he received a similar award from the Day Lewis pharmacy group. In 2014, David was invited to join the Users Group of the Family Health Services Appeal Unit and he attends a General Pharmaceutical Council fitness to practise users group. David sits as a Deputy District Judge in County Courts, and has chaired pharmacy appeal hearings in Wales and has been appointed by the Welsh Government as an adjudicator in other healthcare disputes.
David is admitted to practise in England and Wales and he is on the Roll of Solicitors in Northern Ireland (but does not hold a practising certificate there).
- Advocacy at NHS hearings and in fitness to practise cases
- Business and regulatory advice
- Litigation including judicial review
- Regular contributor to the pharmacy and healthcare press
Does Hunt think establishment payments are "subsidies"?
Senior Healthcare partner David Reissner picks apart Jeremy Hunt's language during Monday's parliamentary debate
Pharmacy Brief - December 2016
Welcome to the December edition of our Pharmacy Brief.
EU law will change the way you dispense: The Falsified Medicines Directive (FMD)
In February, the European Commission announced that the Falsified Medicines Directive will become law across Europe on 9 February 2019.